(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
about
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.Is it time to combine untargeted antifungal strategies to reach the goal of 'early' effective treatment?Evaluation of the use of novel biomarkers to augment antimicrobial stewardship program activities.Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study.(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial
P2860
Q30235457-30BD6B3B-E9F9-434C-A82A-5D7BD3DC2FCEQ33758772-FFF99819-C264-4917-8312-AECA99B852A2Q37551817-5ABBB972-1212-4CF3-819E-7699FBB10011Q40128716-32CA4E4E-B276-4C94-A8D6-E15A731E9E6DQ42358748-FB2B558B-6E29-46C4-A59E-E8B8E65B61BFQ47289498-53286318-C3D6-40A6-B979-27939484C549Q47678193-22893C73-E39A-49AB-A2E9-D266DE9E2150Q49803837-63661740-32AE-4F23-BD4E-35143B11E313Q50072321-B52981C9-E1E9-49C1-9A4D-281170C83FCDQ55105395-5DDC94D4-4CB3-438A-BF73-AB41F6B38E26Q58765160-14752B07-BCB1-46B4-945A-EE404BCC3CC6
P2860
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@en
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@nl
type
label
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@en
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@nl
prefLabel
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@en
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@nl
P2093
P2860
P50
P356
P1476
(1,3)-β-d-Glucan-based antifun ...... aemia: an observational study.
@en
P2093
Elvira Liberto
Gennaro De Pascale
Maria S Vallecoccia
Mario Tumbarello
Massimo Antonelli
Valentina Di Gravio
P2860
P304
P356
10.1093/JAC/DKW112
P407
P577
2016-04-28T00:00:00Z